Literature DB >> 35720234

Level of education, background and clinical stage as prognostic factors according to RMST function in patients with early and locally advanced breast cancer: a single institution experience from Romania.

Irina Niţă1,2, Cornelia Niţipir1,2, Ştefania Andreea Toma3, Alexandra Maria Limbău4, Edvina Pirvu5, Ioana Anca Bădărău1, Ioana Suciu6, George Suciu6, Loredana Sabina Cornelia Manolescu1.   

Abstract

Background and aims: Our aim is to examine the relationship between the level of education, background, tumor size and lymph node status on the treatment outcome in a group of patients with early and locally advanced breast cancer (BC) by using the restricted mean survival time (RMST), which summarizes treatment effects in terms of event-free time over a fixed period of time.
Methods: We evaluated the prognostic values in 143 patients treated for early BC at Elias University Emergency Hospital, Bucharest, Romania and followed up for a maximum of 36 months. The protocol was amended to include the levels of education (gymnasium, high school, or university), the background (urban or rural) and the clinical stage (primary tumor (T) and regional nodes (N)). The methodology consisted in using a Kaplan-Meier analysis and RMST for the entire sample and Cox regression, for the variables with statistical influence. The principal endpoints of the study were overall survival (OS) and progression free survival (PFS).
Results: The level of education had impact both on RMST OS (35.30 vs. 26.70) and death HR (hazard ratio) in the group of patients with general school level, compared with those with graduated university. In this study, the urban or rural background did not impact the outcome, probably because in this study we included predominantly patients from urban areas (83%). Although clinical tumor size measurements did not impact the outcome, the clinical staged lymph node influenced both OS (p=0.0500) and PFS (p=0.0006) for the patients with palpable or imaging proof of lymph node involvement of station 2 or 3. Conclusions: RMST provides an intuitive and explicit way to express the effect of those risk factors on OS and PFS in a cohort of early breast cancer patients. Low level of education and high-grade clinical lymph node status negatively influences the outcome of this cohort of BC patients.

Entities:  

Keywords:  RMST; background; breast cancer; clinical stage; levels of education

Year:  2022        PMID: 35720234      PMCID: PMC9177084          DOI: 10.15386/mpr-1988

Source DB:  PubMed          Journal:  Med Pharm Rep        ISSN: 2602-0807


  38 in total

1.  Introduction to the use of regression models in epidemiology.

Authors:  Ralf Bender
Journal:  Methods Mol Biol       Date:  2009

2.  Breast cancer in Belarus and Ukraine after the Chernobyl accident.

Authors:  Eero Pukkala; Ausra Kesminiene; Semion Poliakov; Anton Ryzhov; Vladimir Drozdovitch; Lina Kovgan; Pentti Kyyrönen; Irina V Malakhova; Liudmila Gulak; Elisabeth Cardis
Journal:  Int J Cancer       Date:  2006-08-01       Impact factor: 7.396

3.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

Review 4.  TNM classification of malignant tumors (Breast Cancer Study Group).

Authors:  Masataka Sawaki; Tadahiko Shien; Hiroji Iwata
Journal:  Jpn J Clin Oncol       Date:  2019-03-01       Impact factor: 3.019

Review 5.  Breast cancer diagnosis: Imaging techniques and biochemical markers.

Authors:  Seyed Hamed Jafari; Zahra Saadatpour; Arash Salmaninejad; Fatemeh Momeni; Mojgan Mokhtari; Javid Sadri Nahand; Majid Rahmati; Hamed Mirzaei; Mojtaba Kianmehr
Journal:  J Cell Physiol       Date:  2018-01-19       Impact factor: 6.384

6.  [Normalization in axillary lymph node management after neoadjuvant therapy for breast cancer].

Authors:  D Wu; S Y Liu; Maimaitiaili Amina; Z M Fan
Journal:  Zhonghua Wai Ke Za Zhi       Date:  2019-02-01

7.  On the restricted mean survival time curve in survival analysis.

Authors:  Lihui Zhao; Brian Claggett; Lu Tian; Hajime Uno; Marc A Pfeffer; Scott D Solomon; Lorenzo Trippa; L J Wei
Journal:  Biometrics       Date:  2015-08-24       Impact factor: 2.571

Review 8.  Risk Factors and Preventions of Breast Cancer.

Authors:  Yi-Sheng Sun; Zhao Zhao; Zhang-Nv Yang; Fang Xu; Hang-Jing Lu; Zhi-Yong Zhu; Wen Shi; Jianmin Jiang; Ping-Ping Yao; Han-Ping Zhu
Journal:  Int J Biol Sci       Date:  2017-11-01       Impact factor: 6.580

9.  Predicting the extent of nodal involvement for node positive breast cancer patients: Development and validation of a novel tool.

Authors:  Ingrid van den Hoven; David van Klaveren; Nicole C Verheuvel; Raquel F D van la Parra; Adri C Voogd; Wilfred K de Roos; Koop Bosscha; Esther M Heuts; Vivianne C G Tjan-Heijnen; Rudi M H Roumen; Ewout W Steyerberg
Journal:  J Surg Oncol       Date:  2019-07-23       Impact factor: 3.454

Review 10.  The Role of Beta HPV Types and HPV-Associated Inflammatory Processes in Cutaneous Squamous Cell Carcinoma.

Authors:  Mircea Tampa; Cristina Iulia Mitran; Madalina Irina Mitran; Ilinca Nicolae; Adrian Dumitru; Clara Matei; Loredana Manolescu; Gabriela Loredana Popa; Constantin Caruntu; Simona Roxana Georgescu
Journal:  J Immunol Res       Date:  2020-04-06       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.